Story perspectives

Psychedelics' Receptor Breakthrough Paves Way for Healing Therapies

7/20/2025

36 4

Summary

Story summary

A groundbreaking study uncovers that classical psychedelics such as LSD, psilocybin, and mescaline engage a wide array of serotonin, dopamine, and adrenergic receptors, far surpassing the previously recognized 5-HT2A receptor. This extensive receptor interaction not only sheds light on their healing power for mental health issues but also opens doors for creating focused, non-hallucinogenic therapies. Understanding these dynamics is vital for the future of psychedelic medicine.

1 of 1

Story summary

A groundbreaking study uncovers that classical psychedelics such as LSD, psilocybin, and mescaline engage a wide array of serotonin, dopamine, and adrenergic receptors, far surpassing the previously recognized 5-HT2A receptor. This extensive receptor interaction not only sheds light on their healing power for mental health issues but also opens doors for creating focused, non-hallucinogenic therapies. Understanding these dynamics is vital for the future of psychedelic medicine.